vote

trial

Kala Pharmaceuticals Inc

crash

$KALA   Haha, shares now crashing -8% as longs lost all profits from p/m.

sell

$KALA 

Tanking like hell 
The sell off is crazy

$KALA  Not looking good----sell at the first pump and rebuy if you can to make up losses.

option

$KALA Shorts have No protection here as there are No call options.

$KALA no option chain, 1.3M float, 100% utilization, SSR restricted… this puppy is going to lose its mind.

short

$KALA Short tools pretending to be long on this forum, flush them in the toilet!

$GNS Received news that’ll ruin a shorts day.

$GMBL SSR tomorrow and shorts tapped out…don’t know what the actual SI is BUT seeing as it’s down -45% since R/S and -50% leading into it, I’d say it’s absurd!

$COSM  🤣🤣🤣🤑😂💥💯
You need to know shit coming money on the way mother fucker shorts are cornered!!!

level

$KALA I have never seen after hours action like this and level two pricing isn’t even close. WTF.

$KALA  
Ya the shorts are raising the panic level.

KPI-012 had Complete Healing after 2-4 weeks on 1b trial!

ALSO RESULTS ON TRIALS TO COME 🔥🔥🔥🔥 $100+ EASY!!!!!

Guys remember, they haven’t even dropped phase 2/3 clinic trial news yet 👀

$COMS Holding with absolutely no fear , definitely gonna leg up.

$KALA is the one up 500% on Phase 2 results where FDA approval of any possible kind is many years away and where the company is burning through $80 million per year for zero results.

$PBLA  
multiple phase 3 trail ..price 8 cents ..dirt cheap $KALA $RSLS $ATNF $PTPI

but pretty dam close with the current study habits I have.

bull

$KALA may go up 103% if the bull pattern is confirmed.

Glad to see those smart bulls quietly buying.

$KALA the bull pattern is confirmed &amp; a BUY signal is issued @ https://bit.ly/2IkK2iB.

Hope everyone finds this gem ;)  
  
GLTA BULLS

$COSM  BEST BULLS EVER HERE 🤝🤝🤝🤝🙏🤝🤝🙏🤝🤝🤑🤑🤑🥳💯💥🙏
LET&#39;S GO 

$KALA $NUWE $HKD $BIOR

Sitting here as Long as it Need to get the 3,5$

Bios like $KALA or $GMVD are on Fire now

Good day for the $QQQ Bulls

$KALA come over to SMMT for a bull run🚀 it’s been green all day

$COSM  good job bulls holding the line comparing to $KALA  $HKD tomorrow will send us free 👍

2023 is setting up for a year for the bulls with ALL the PR’s  lined up.

profit

We alerted the SELL signal at $13.82 and we were able to close this one with profit at $12.62 🔏

We alerted the SELL signal at $18.32 and we were able to close this one with profit at $15.36 📊

We alerted the BUY signal at $18.06 and we were able to close this one with profit at $21.802 😎

So definitely taking profits over to NRBO.

With my profits I will load a lot more GMBL shares ;) 
 
Thanks for the great call on GIGM!

Now i am calling $tcbp for a nice profit from these levels.

Now i am calling $GMVD for a nice profit from these levels.

Max potential profit from alerts today: 719%.

Hit 133% profit overnight! 💰💰 
 
⬇️For more Targets &amp; Stock News ⬇️ 
https://stockresearchtoday.com/massive-bounce-potential-for-this-one-tech-stock/ 
 
Communicated Disclaimer (always set stops and take profit!)

news

$KALA went to $45 on news not even close to this good.

$BVXV huge news out on this today and no one has even recognized it yet   after they speak tonight this thing will light up green   I am ready for a big move tomorrow   $KALA $MSGM $NUWE

$GENE remember $KALA went from $5 to $50 in 3 days … this is kala in making with better news

Ticker $GMVD is up 100%+ in pre-market on massive PATENT NEWS .

Ticker $GMVD is up 100%+ in pre-market on massive PATENT NEWS.

$GMVD WOW GOING TO TOUCH $7, GREAT PATENT NEWS COULD RUN LIKE $KALA $FOXO

$RSLS $KALA $NUZE $TCBP yes  tcbp looks  good with yesterday’s news

SELLAS Life Sciences Group Inc

buying

$SLS  I wont be buying anymore shares until the CEO can show is company is worth at least 150m marketcap 
 
Look at the 3 year chart be warned the CEO is a scam artist and a liar

You are better off hoarding cash vs buying into a company where the staff sells free shares and does not deserve pay raises during a economic crisis/recession.

$SLS  No one should be buying in at these prices though.

$SLS SERIOUSLY STOP FUCKING RUNNING ALL THE BUYING OTC DARK POOL!!!

This MM is refusing to honor order flow, they are refusing to move the price higher when buying comes in, they are dictating price direction and that&#39;s not their fucking job.

HOW THE FUCK DID THEY JUST FILL 24k BUYING VOLUME AND NOT A SINGLE $.01 MOVE!!!!

but buying inflow and a 5K buy order and yet POS MM will not let it fucking go!! !

application

Gfh009 is a joke and will ruin this stock until 3d meds sees fda approval for aml gps.

16/16 
In all 3 Options GPs gets FDA approval due to QOL, venclexta, onureg, oralAz - all Cr1 salvage agents are highly toxic.

This concerns me, we get the dreaded not statistically relevant ruling from the FDA.

- OUTRIGHT LIE saying THEN 52 weeks - PURE BS 
- OUTRIGHT LIE saying THEN patients need to Die 
Co is now on RECord Reiterating 80 Events, patient deaths in Q1Q2 
That is the fda green light moment.

announcement

You fucked up and shorted NCI non dilutive funding announcement and patients living longer news.

$SLS they supposedly hired a lawyer fill time and this was never announced .

The shorts feeling the pain on their announcement.

$SLS For those predicting some big announcement from Sellas on the 14th at the Regal symposium, you are going to be terribly disappointed.

investor

What a freaking smack in the face to investors.

Angelos has intentionally screwed the long term investor.

$SLS I find it arrogant that SLS would even investors were concerned about their SIVB exposure.

but after doing an offering and the way the market is, the company should be giving some communication,  otherwise you are showing you really don&#39;t care about long term  investors,  personally  I&#39;m not impressed with the way it&#39;s been handled.

$SLS This is a JOKE and the JOKE is on the real investors ☹️

$SLS SLS investors have two problems now.

If you’re an experienced investor and you buy this scam, you deserve to lose you your investment.

$SLS No one should buy  in to this unless you are new investor.

They need to communicate and support their investors and shareholders.

Scary that I bought 2 years ago 9000 shares $6.50 average price to see this today just seems like he doesn’t care at all for investors why would he?

$SLS my vote is get GPS green lighted for FDA approval and ramp this company up for M&amp;A.  GPS and GFH009 are high potential assets

$SLS $XBI  
when republicans take control of the house  and all votes are finalized , we are going to see another bullish run like we did today 
 
Election Day | 2022 Statewide General Election 
Tue, Nov 8 2022, 6:30am - 7:30pm

It reported positive outcomes in pleural mesothelioma patients, including:
Improved survival: Study patients lived around 11 months.

PROC data are excellent compared to any combo trials.

But yesterdays paper also has me considering, if there isn&#39;t a deal with $mrk or $BMY or some other CPI BP  
--- That data is Best In Class - best in clinic, best in trial too.

Now phase 3 trial is showing similar results to date where patients are living longer after Galinpepimut-S up to 1.5 year longer is a breakthrough for AML patients.

Positive trial data/results supported with bullish news and sentiment! 4.

The nation’s best means the O&#39;Neal Comprehensive Center in Alabama have access to the latest therapies, cutting-edge clinical trials and the expertise needed to treat their cancer.

Gps is doing what it has done in every single trial and its the reason Patients are living 3 fold longer than patients on best available treatments.

Treatment with GFH009 resulted in 90 to 100 percent cancer inhibition at dose levels equivalent to those already demonstrated to be safe in patients in the ongoing Phase 1 trial with no viable cancer cells at the highest dose levels.

patient

* Best Available Therapy offers 6-8 months of Overall Survival  
* All pooled Regal patients, BAT and Gps combined, is 16 months.

* Best Available Therapy offers 6-8 months of Overall Survival 
* All pooled Regal patients, BAT and Gps combined, is 16 months.

- Best available treatment 6-8 months of os.

- Cured GPS patients, continue to elongate the OS curve in Gps favor every day that goes by.

$SLS In addition to GPs FDA approval for AML secondary Remission patients - Gps + Keytruda/Checkpoint Inhibition is also best in class for Ovarian cancer patients.

$SLS NCT update, nice…
They target 140 patients in 110 investigational sites.

$SLS With news on its way, the confidence built in the science, fear factor is gone.

$SLS No breaking news here regarding Sellas, and its well above my understanding,

$SLS good news, at the current rate and the ridiculous prices, in about a month you can buy this company for free.

My guess is that they generated ~3m revenue through the EAP, which would be really great news.

This is a rare opportunity that you know the news is grossly good(it convinced in investor(s)) and still have the chance to load and make 50 to 100% in .month or so.

plenty of upside if there is positive news.

$SLS they picked a great day for this news. lol

So much for this offering being good news.

cancer

These patients experienced about 35% longer survival than has been reported for other second-line therapies.

Good cancer stock from what I hear in 2028.

$MRK Ovarian cancer data final P2 results are better than any other drugs by a mile.

They address a broad range of cancer indications.

$SLS Gps arm 22 months of median Overall Survival  
Best Available Therapy 8.

Ardelyx Inc

approval

$ARDX what fucking morons are selling it’s approved there are some real dumb fucks involved in this stock good let them get the fuck out. Pussys

$ARDX if we have no approval  you know they are corrupt. .

$ARDX with a 98% chance of fda approval within a few weeks, what is this crap?

Denial of approval of such product  will need a strong justification or presence of significant risk (which is not applicable for Tenapanor as elaborated in the above detailed  
analysis).

but not expecting a ton of juice upon approval 🤞

$ARDX with all due respect, this price action today is embarrassing…nasdaq up 6% we can’t even break $1.30 embarrassing for real… I won’t even be surprised if we get approval next week and we stay stagnant for a bit.

The issue raised was probably one of the only negatives for approval:  The fact that we are using &#39;surrogate&#39; endpoints rather than the correlated clinical outcome.

Tena is already approved for IBS with a solid safety profile, and phosphorus management is a real issue in the CKD community with only binders being available.

insider

One red flag in this company, despite one director buying 1m worth recently, is the low insider ownership.

$ARDX less than one dollar soon insiders doing, given how corrupt the board and CEO are .

$ARDX company doesn’t say anything, insiders don’t buy, stock trades like total crap.

Kind of thing you expect to happen to a stock if the CEO is complicit in a INSIDER Trading SCHEME. .

Those laxatives your taking are not working, you need the full Fleets treatment, a complete system flush.

I still remember listening to the meeting and getting mad at Alikhani, the so called patient&#39;s advocate.

The subsequent increase in intraluminal pressure leads to decreased intestinal blood flow, and in the case of our patient, intestinal ischemia.

They got something that improve the quality of life for dialysis patients and you guys called the trash company.

$ARDX&quot; I am a board-certified nephrologist for 30 years and was very disappointed to say the least by the denial of application of Tenapanor for hyperphosphatemia in patients with CKD.

However, the enrichment strategy did not appear to reliably identify patients who would have a larger treatment response to tenapanor.

As you think about your decision, I’d like to ask you to remember me and the other patients out there like me who are looking for solutions to help them.

Company sitting on the best fundamentals ever to date and we get treated to these stupid 1 liner worthless post.

However when patients get discharged compliance will still remain an issue because nurses and doctors aren’t there watching over them and making sure they take their meds.

trading

Obvious, as hell looking at tape today this trading was far from organic.

↳ Why are you paying to be in a Trading Room?

$ARDX 
With these absurd disconnected 80-100million-share volumes, trading price purely a construction of Dark pool, HFT, MM share-swapping, etc.

In the scientific community as well as in trading feeling get fucked.

reason

what a BS TREE SHAKE by MM&#39;s today was zero reason to let this drop like they did. .

I see no reason to hold or add at this point.

There would be no other reason for the timing.

$ARDX Ok, the only reason to deny our drug is negligible efficacy.

but that the FDA had denied access to for reasons no one understood.

Must be the reason this can’t get past 1.5

There is no reason for it to fall today like this!

He is one of the reasons that the SP stays down.

And it was an unequivocal vote for approval. IMO

For the ADCOM had cast their votes, and they were overwhelmingly positive.

There&#39;s enough data and votes to show XPHOZAH is good to go.

I am encouraged by the committee&#39;s vote.”

Depending on the adcom vote this can also be good to buy afterwards.

ISBRELA is beating every projection and XPHOZAH should get a positive vote.

Easy 3x to 4x upon a positive adcom vote.

In a moment I will be getting into exactly how all of the factors VASTLY favor Xphozah for a positive adcom vote.

Likeliest outcome, Ad Com panel votes strongly in favour and FDA approves.

Most of us should know by now that the trials of Tenapanor in mono therapy and combination therapy with phosphate binders were both positive.

$ARDX Excellent XPHOZAH clinical benefit data presented at American Society of Nephrology.

With over 1,100 patients treated with XPHOZAH in clinical studies in the U.S. as well as clinical data generated by our partner Kyowa Kirin in Japan, we believe the impact that this first-in-class treatment could have for CKD patients on dialysis is clear.

We congratulate our partners on their work, and we would like to express our gratitude to them, the hundreds of patients that participated in their clinical studies in Japan, and the medical staff that supported these patients.

The incorporation of the patient voice into the clinical trial design and evaluation of tenapanor is a huge step forward for patients.”

$ARDX Looking good, would be nice to finish the day in the 4&#39;s 
 
Still waiting on positive news from the company.

$ARDX very good fda news on this conference call

$ARDX just keeps doing things well, and good news should arrive soon!

If the trend of script numbers is anything to go by, guidance could be way better than Wall Street expects giving us a nice boost before FDA news.

$ARDX LOL, soon Xenopah News  😁 
Stay in, or buy

$ARDX good news coming man let’s goooooo

$AKBA within 3  to 4 weeks this stock could be over 2 heading to three like $ARDX .. gsk approval has helped.. fda news, ema opinion/ approval, partnership..

$ARDX I am thrilled that the chairwoman of our Adcom gave monotherapy a thumbs up.

This is 100% normal and part of the growth of a strong company with excellent fundamentals and an FDA approval coming this year.

Better than money in the bank with soon resubmission and approval 2-6 months later!

So glad that I bought before ADCOM meeting.

And this is just a beginning, FDA approval will take it to the skies.

Pretty Bullish ER going to give us an update on FDA when and etc. .

$ARDX This company is sitting on a mountain of great fundamentals.. 40++ medical patents ,,, 40+ more in application status 1 drug approved IBSRELA 1 drug almost aproved XPHOZAH a kidney drug that could pull an annual billion dollar + revenue.

🎉

Have a great evening bulls and longs. 🍻🍻🍻

Hold strong bulls we’re not going anywhere 😤

$ARDX I’ll see you bulls in the 3.90s today 😤

$ARDX wow and just like that there’s no more bulls 🤣🤣🤣

A close above 4 will be huge for the bulls

Cheers and see you all tomorrow bulls and longs. 🍻

$ARDX  Looks like a bull flag on the daily morning here.

$ARDX $APRN $BLBX Have a great night, Bulls and Bull-ettes! !

KALA

Kala Pharmaceuticals Inc

-9.01%

$16.65 - $15.15

Jan, 3, 2023

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Mar, 13, 2023

Nov, 8, 2022

Divihomes is Now Live

ARDX

Ardelyx Inc

23.58%

$3.35 - $4.14

Jan, 19, 2023

Dec, 15, 2022

KALA

Kala Pharmaceuticals Inc

-9.01%

$16.65 - $15.15

Jan, 3, 2023

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Mar, 13, 2023

Nov, 8, 2022

ARDX

Ardelyx Inc

23.58%

$3.35 - $4.14

Jan, 19, 2023

Dec, 15, 2022

Dec, 14, 2022

Nov, 21, 2022

Nov, 18, 2022

Nov, 12, 2022

Nov, 1, 2022

Oct, 31, 2022

Oct, 25, 2022

Oct, 11, 2022